CHICAGO--(BUSINESS WIRE)--Marcus & Boxerman announces that it is investigating claims of potential misrepresentations by Sientra, Inc. (“Sientra” or the “Company”) (NASDAQ: SIEN). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.
To join this class action lawsuit, please contact Michael Boxerman, Esquire, of Marcus & Boxerman, at 312-216-2730, or via email at email@example.com.
The investigation concerns whether the Company violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. On September 24, 2015, the Company disclosed that the U.K.’s Medicines and Healthcare products Regulatory Agency has suspended distribution of its Silimed products. When the truth was revealed, shares dropped, causing investors harm.
No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.